+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
At-home Drug of Abuse Testing Market by Distribution Channel (Online, Pharmacy Retail), Test Type (Multi-Drug Panel, Single Drug), Sample Type, Technology, End User - Global Forecast 2025-2030- Product Image
At-home Drug of Abuse Testing Market by Distribution Channel (Online, Pharmacy Retail), Test Type (Multi-Drug Panel, Single Drug), Sample Type, Technology, End User - Global Forecast 2025-2030- Product Image
Sale

At-home Drug of Abuse Testing Market by Distribution Channel (Online, Pharmacy Retail), Test Type (Multi-Drug Panel, Single Drug), Sample Type, Technology, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716235
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The at-home drug of abuse testing market is undergoing meaningful transformation, propelled by technological advancements and evolving consumer preferences. Senior decision-makers will find a landscape shaped by new regulatory developments, shifting supply chains, and a rising demand for accessible, confidential screening solutions.

Market Snapshot: At-home Drug of Abuse Testing Market

The at-home drug of abuse testing market grew from USD 2.88 billion in 2024 to USD 3.10 billion in 2025. It is expected to continue growing at a CAGR of 7.24%, reaching USD 4.38 billion by 2030. This expansion emphasizes sustained interest from individuals and institutions seeking reliable, rapid, and user-friendly testing. Drivers include the mainstream adoption of self-testing, regulatory updates to ensure product quality, and digital innovations that simplify both collection and results interpretation for consumers and healthcare providers.

Scope & Segmentation

  • Distribution Channels: Online (ecommerce platforms, manufacturer websites) and pharmacy retail (chain and independent pharmacies).
  • Test Types: Multi-drug panels (three, five, and ten-panel formats) and single-drug tests targeting substances such as amphetamines, cocaine, marijuana, and opiates.
  • Sample Types: Urine, hair, saliva (oral fluid dip card, saliva swab), and sweat-based assays.
  • Technologies: Chromatography (gas and liquid chromatography-mass spectrometry), immunoassay (competitive and sandwich), conventional and digital lateral flow devices.
  • End Users: Clinics (occupational programs, substance abuse clinics), individuals, and pharmacies (chain, independent).
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East, Africa (including UK, Germany, France, UAE, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, Korea, Indonesia and more).
  • Key Companies: Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Abbott Rapid Diagnostics, Premier Biotech, LLC, American Screening Corporation, Express Diagnostics International, LLC, Access Bio Inc., Diagnostic Automation/Cortez Diagnostics, Inc., Certest Biotec S.L., Nal von Minden GmbH.

Key Takeaways for Decision-makers

  • Technological innovation—especially digital lateral flow and integration with smartphones—is redefining the way at-home drug testing is conducted and experienced.
  • Regulatory flexibility is enabling faster product launches, but it also increases the need for ongoing quality and compliance management across diverse jurisdictions.
  • Consumer preferences are driving companies to design solutions that prioritize convenience, privacy, and reliability, impacting both product features and distribution approaches.
  • Public-private collaboration is expanding access, particularly in regions where mobile health initiatives and retail pharmacy engagement are bridging service gaps.
  • Market participants must build agile, resilient strategies that address potential price pressures and supply chain disruptions stemming from geopolitical and economic shifts.

Tariff Impact on the At-home Drug of Abuse Testing Market

New United States tariffs scheduled in 2025 are set to affect imported components critical to test manufacturing, including reagents, cartridges, biosensors, and analytical instruments. Manufacturers are revising procurement strategies—shifting toward nearshoring or diversified sourcing—while balancing the risks of increased costs and potential launch delays. For end users, these adjustments may translate to incremental price shifts and slower access to new products. Long-term, the industry may see increased domestic investment and vertical integration in pursuit of resilient supply chains and stabilized consumer pricing.

Methodology & Data Sources

This report employs a robust mixed-methods approach. Analysts combined secondary research—peer-reviewed journals, regulatory filings, and industry white papers—with in-depth interviews of executives, providers, distributors, and regulatory experts. Procedures included triangulation and statistical benchmarking to ensure reliability, accuracy, and transparency in trend identification.

Why This Report Matters

  • Gain a clear roadmap through complex regulatory, technological, and regional variations affecting the at-home drug abuse testing industry.
  • Identify strategic opportunities for investment, innovation, and partnership—drawing from in-depth segmentation and competitive analysis.
  • Access actionable, unbiased insights that reinforce supply chain strategies and highlight emerging consumer and compliance expectations.

Conclusion

The at-home drug of abuse testing market is poised for strategic growth, powered by evolving technology and shifting global supply chains. Decision-makers using this report are equipped to navigate challenges and capture new opportunities in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing consumer adoption of saliva-based at-home drug testing kits for prescription monitoring
5.2. Integration of smartphone apps with at-home drug tests to provide instant results and telehealth linkage
5.3. Rising demand for multi-panel at-home test strips detecting opioids amphetamines and benzodiazepines
5.4. Development of non-invasive sweat biosensor patches for continuous at-home substance use monitoring
5.5. Expansion of direct-to-consumer distribution channels through e-commerce and subscription services for testing
5.6. Increasing partnerships between diagnostic manufacturers and telemedicine providers for integrated testing solutions
5.7. Streamlining FDA regulatory pathways for at-home drug tests to accelerate market approvals and adoption
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. At-home Drug of Abuse Testing Market, by Distribution Channel
8.1. Introduction
8.2. Online
8.2.1. Ecommerce Platforms
8.2.2. Manufacturer Websites
8.3. Pharmacy Retail
8.3.1. Chain Pharmacy
8.3.2. Independent Pharmacy
9. At-home Drug of Abuse Testing Market, by Test Type
9.1. Introduction
9.2. Multi-Drug Panel
9.2.1. Five Panel
9.2.2. Ten Panel
9.2.3. Three Panel
9.3. Single Drug
9.3.1. Amphetamines
9.3.2. Cocaine
9.3.3. Marijuana
9.3.4. Opiates
10. At-home Drug of Abuse Testing Market, by Sample Type
10.1. Introduction
10.2. Hair
10.3. Saliva
10.3.1. Oral Fluid Dip Card
10.3.2. Saliva Swab
10.4. Sweat
10.5. Urine
11. At-home Drug of Abuse Testing Market, by Technology
11.1. Introduction
11.2. Chromatography
11.2.1. Gas Chromatography-Mass Spectrometry
11.2.2. Liquid Chromatography-Mass Spectrometry
11.3. Immunoassay
11.3.1. Competitive
11.3.2. Sandwich
11.4. Lateral Flow
11.4.1. Conventional
11.4.2. Digital
12. At-home Drug of Abuse Testing Market, by End User
12.1. Introduction
12.2. Clinics
12.2.1. Occupational Programs
12.2.2. Substance Abuse Clinics
12.3. Individuals
12.4. Pharmacies
12.4.1. Chain
12.4.2. Independent
13. Americas At-home Drug of Abuse Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa At-home Drug of Abuse Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific At-home Drug of Abuse Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Laboratory Corporation of America Holdings
16.3.2. Quest Diagnostics Incorporated
16.3.3. Abbott Rapid Diagnostics
16.3.4. Premier Biotech, LLC
16.3.5. American Screening Corporation
16.3.6. Express Diagnostics International, LLC
16.3.7. Access Bio Inc.
16.3.8. Diagnostic Automation/Cortez Diagnostics, Inc.
16.3.9. Certest Biotec S.L.
16.3.10. Nal von Minden GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AT-HOME DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. AT-HOME DRUG OF ABUSE TESTING MARKET: RESEARCHAI
FIGURE 26. AT-HOME DRUG OF ABUSE TESTING MARKET: RESEARCHSTATISTICS
FIGURE 27. AT-HOME DRUG OF ABUSE TESTING MARKET: RESEARCHCONTACTS
FIGURE 28. AT-HOME DRUG OF ABUSE TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AT-HOME DRUG OF ABUSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY FIVE PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY FIVE PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEN PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEN PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY THREE PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY THREE PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COCAINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COCAINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MARIJUANA, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MARIJUANA, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OPIATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OPIATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUID DIP CARD, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUID DIP CARD, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COMPETITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SANDWICH, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SANDWICH, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CONVENTIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DIGITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DIGITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OCCUPATIONAL PROGRAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OCCUPATIONAL PROGRAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SUBSTANCE ABUSE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SUBSTANCE ABUSE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDIVIDUALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDIVIDUALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 177. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 180. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 181. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2024 (USD MILLION)
TABLE 182. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2025-2030 (USD MILLION)
TABLE 183. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 184. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 185. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 186. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 187. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2024 (USD MILLION)
TABLE 188. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2025-2030 (USD MILLION)
TABLE 189. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 190. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 191. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 192. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 193. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 196. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 197. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 198. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 199. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 200. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 201. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 204. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 205. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 210. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 211. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2024 (USD MILLION)
TABLE 212. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2025-2030 (USD MILLION)
TABLE 213. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 214. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 215. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 216. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 217. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2024 (USD MILLION)
TABLE 218. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2025-2030 (USD MILLION)
TABLE 219. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 220. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 221. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 222. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 223. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 226. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 227. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 228. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 229. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 230. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 231. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 234. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 235. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 236. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & A

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this At-home Drug of Abuse Testing market report include:
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Abbott Rapid Diagnostics
  • Premier Biotech, LLC
  • American Screening Corporation
  • Express Diagnostics International, LLC
  • Access Bio Inc.
  • Diagnostic Automation/Cortez Diagnostics, Inc.
  • Certest Biotec S.L.
  • Nal von Minden GmbH

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.38 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Drug of Abuse Testing Market by Sample Type (Hair, Oral Fluid, Urine), Test Technology (Chromatography, Immunoassay), End User, Drug Panel - Global Forecast 2025-2030 - Product Image

Drug of Abuse Testing Market by Sample Type (Hair, Oral Fluid, Urine), Test Technology (Chromatography, Immunoassay), End User, Drug Panel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032 - Product Image

Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032

  • Report
  • 235 Pages
  • Global
From
At-Home Drug of Abuse Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

At-Home Drug of Abuse Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Drug of Abuse Testing Market by Product Type, Sample, Drug, and End User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Drug of Abuse Testing Market by Product Type, Sample, Drug, and End User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 220 Pages
  • Global
From
Drugs of Abuse Testing - Global Strategic Business Report - Product Image

Drugs of Abuse Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.